Next Article in Journal
Monoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment
Next Article in Special Issue
Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2
Previous Article in Journal
Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer’s Disease
Previous Article in Special Issue
Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review
 
 
Article

Article Versions Notes

Pharmaceuticals 2020, 13(12), 425; https://doi.org/10.3390/ph13120425
Action Date Notes Link
article xml file uploaded 27 November 2020 05:21 CET Original file -
article xml uploaded. 27 November 2020 05:21 CET Update -
article pdf uploaded. 27 November 2020 05:21 CET Version of Record -
article html file updated 27 November 2020 05:23 CET Original file -
article xml file uploaded 27 November 2020 10:23 CET Update -
article xml uploaded. 27 November 2020 10:23 CET Update https://www.mdpi.com/1424-8247/13/12/425/xml
article pdf uploaded. 27 November 2020 10:23 CET Updated version of record https://www.mdpi.com/1424-8247/13/12/425/pdf
article html file updated 27 November 2020 10:24 CET Update -
article html file updated 23 July 2022 02:46 CEST Update https://www.mdpi.com/1424-8247/13/12/425/html
Back to TopTop